National United AMR Organism/disease Antimicrobial M. Website; Tuberculosis States surveillance between susceptibilities tuberculosis reports; Surveillance health of System102 departments M. tuberculosis publications and CDC MeningNet United AMR Organism/disease Antimicrobial N. n/a (CDC)102 States surveillance between susceptibilities meningitidis (capacity of (28 cities) (N. 10 of MeningNet was meningitidis) health N. meningitidis increased to departments conduct AMR and CDC’s surveillance Meningitis since and Vaccine Preventable Diseases Branch) GISP102 United AMR Organism/disease Antimicrobial N. Website; States surveillance between susceptibilities gonorrhoeae annual (N. STI clinics, of strains of N. reports; regional gonorrhoeae laboratories, publications and the CDC Project United AMR Corporate n/a n/a Susceptibility S. aureus Website; ICARE130, 207, States surveillance funding data of clinical Enterococcus 213, 244 and isolates spp. (subset of antibiotic P. aeruginosa publications; hospitals from consumption Enterobacter method of ICU component spp. K. reporting of NNIS, now pneumoniae DDD differed part of NHSN) E. coli to WHO
National Tuberculosis Surveillance System102 United States AMR surveillance between health departments and CDC Organism/disease Antimicrobial susceptibilities of M. tuberculosis M. tuberculosis Website; reports; publications MeningNet (CDC)102 (capacity of MeningNet was increased to conduct AMR surveillance since United States (28 cities) AMR surveillance (N. meningitidis) between 10 health departments and CDC’s Meningitis and Vaccine Preventable Diseases Branch) Organism/disease Antimicrobial susceptibilities of N. meningitidis N. meningitidis n/a GISP102 United States AMR surveillance (N. between STI clinics, regional laboratories, and the CDC Organism/disease Antimicrobial susceptibilities of strains of N. gonorrhoeae N. gonorrhoeae Website; annual reports; publications Project ICARE130, 207, 213, 244 (subset of hospitals from ICU component of NNIS, now part of NHSN) United States AMR surveillance and antibiotic consumption Corporate funding n/a n/a Susceptibility data of clinical isolates S. aureus Enterococcus spp. P. aeruginosa Enterobacter spp. K. pneumoniae E. coli Website; publications; method of reporting DDD differed to WHO